Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma

NCT01142232 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide plus Melphalan during autologous stem cell transplantation
DRUG: Lenalidomide maintenance

Sponsor

Attaya Suvannasankha

Collaborators

[object Object]